AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Association of Equine Practitioners (AAEP).
White
N A
NA
Marion duPont Scott Equine Medical Center, Virginia-Maryland Regional College of Veterinary Medicine, Leesburg 22075, USA.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D003002:Clonixin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004348:Drug Labeling; D005839:Gentamicins / Q000627:therapeutic use; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses; D010653:Phenylbutazone / Q000627:therapeutic use; D012952:Societies; D014481:United States; D014730:Veterinary Medicine
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002511:Cephalosporins; D005839:Gentamicins; C053503:ceftiofur; C014558:flunixin meglumine; D010653:Phenylbutazone; D003002:Clonixin